CALABRO', Maria
 Distribuzione geografica
Continente #
EU - Europa 7.214
NA - Nord America 6.160
AS - Asia 3.801
SA - Sud America 1.099
Continente sconosciuto - Info sul continente non disponibili 113
AF - Africa 98
OC - Oceania 5
Totale 18.490
Nazione #
US - Stati Uniti d'America 6.065
RU - Federazione Russa 3.502
SG - Singapore 1.592
CN - Cina 1.140
BR - Brasile 974
IE - Irlanda 930
SE - Svezia 804
UA - Ucraina 503
DE - Germania 419
HK - Hong Kong 401
VN - Vietnam 262
GB - Regno Unito 228
IT - Italia 216
FR - Francia 212
FI - Finlandia 209
IN - India 113
CA - Canada 48
TR - Turchia 47
AR - Argentina 40
BD - Bangladesh 38
PL - Polonia 37
IQ - Iraq 33
MX - Messico 32
BE - Belgio 31
ZA - Sudafrica 29
ES - Italia 24
EC - Ecuador 23
IR - Iran 23
JP - Giappone 21
AT - Austria 20
MA - Marocco 19
NL - Olanda 19
PK - Pakistan 18
UZ - Uzbekistan 17
CO - Colombia 16
ID - Indonesia 16
CI - Costa d'Avorio 14
VE - Venezuela 13
TN - Tunisia 12
CZ - Repubblica Ceca 11
AZ - Azerbaigian 9
CL - Cile 8
MY - Malesia 8
PE - Perù 8
PY - Paraguay 8
SA - Arabia Saudita 8
DZ - Algeria 7
IL - Israele 7
KE - Kenya 7
LV - Lettonia 7
NP - Nepal 7
RS - Serbia 6
AE - Emirati Arabi Uniti 5
CR - Costa Rica 5
EU - Europa 5
KZ - Kazakistan 5
OM - Oman 5
PH - Filippine 5
AL - Albania 4
CH - Svizzera 4
ET - Etiopia 4
SN - Senegal 4
UY - Uruguay 4
BN - Brunei Darussalam 3
DK - Danimarca 3
GR - Grecia 3
MD - Moldavia 3
SK - Slovacchia (Repubblica Slovacca) 3
SR - Suriname 3
AM - Armenia 2
AU - Australia 2
GE - Georgia 2
HR - Croazia 2
JM - Giamaica 2
JO - Giordania 2
KG - Kirghizistan 2
KR - Corea 2
LT - Lituania 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
QA - Qatar 2
RO - Romania 2
SV - El Salvador 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
EE - Estonia 1
EG - Egitto 1
GT - Guatemala 1
GY - Guiana 1
LU - Lussemburgo 1
MK - Macedonia 1
ML - Mali 1
MN - Mongolia 1
NI - Nicaragua 1
NR - Nauru 1
Totale 18.375
Città #
Moscow 1.064
Jacksonville 950
Dublin 930
Singapore 819
Ashburn 719
Chandler 601
Nyköping 482
Dallas 411
Hong Kong 400
Beijing 360
San Jose 261
Dearborn 167
The Dalles 165
Princeton 154
Cambridge 152
Medford 152
Dong Ket 140
Lauterbourg 139
Los Angeles 130
Des Moines 126
Ann Arbor 118
Boardman 106
Tianjin 74
Buffalo 67
Guangzhou 64
São Paulo 64
New York 60
Munich 58
Woodbridge 57
Council Bluffs 56
Jinan 55
Lancaster 54
Ho Chi Minh City 51
Messina 47
Wilmington 43
San Mateo 41
Redondo Beach 39
Shenyang 39
Rio de Janeiro 36
Turku 33
Bremen 31
Brussels 31
Warsaw 31
Houston 29
Pune 29
Augusta 27
Nanjing 26
Frankfurt am Main 23
Atlanta 22
Brasília 22
Chennai 22
Montreal 22
Orem 22
Santa Clara 22
Shanghai 22
Belo Horizonte 21
Leawood 21
Campinas 20
Helsinki 20
Tokyo 20
Hangzhou 19
Hanoi 19
Nanchang 19
Shenzhen 19
Seattle 18
Ardabil 17
Haikou 17
Vienna 17
Chicago 16
Hebei 16
Ningbo 16
Rome 16
Tashkent 16
Brooklyn 15
Abidjan 14
Amsterdam 14
Mexico City 14
Porto Alegre 14
Taizhou 14
Johannesburg 13
London 13
Manchester 13
Milan 13
Mumbai 13
Curitiba 12
Phoenix 12
San Francisco 12
Washington 12
Auburn Hills 11
Boston 11
Francofonte 11
Guayaquil 11
Manaus 11
Poplar 11
Taiyuan 11
Baghdad 10
Fortaleza 10
Goiânia 10
Hyderabad 10
Stockholm 10
Totale 10.517
Nome #
{ [1.1.1.] CRYPTAND/THYMOL BLUE } : A PROTOTYPE OF MOLECULAR APPARATUS FOR SPECTROPHOTOMETRIC AUTOMATIC STUDIES 265
{[1.1.1.]CRYPTAND/THYMOL BLUE}: A PROTOTYPE OF MOLECULAR APPARATUS FOR SPECTROPHOTOMETRIC AUTOMATIC STUDIES ON PH-RATE PROFILE OF DRUGS 225
Bergamot (Citrus bergamia Risso) as a source of nutraceuticals: Limonoids and flavonoids 213
Isoflavone Aglycons-Sulfobutil Ether-beta-Cyclodextrin Inclusion Complexes: in Solution and Solid State Studies 195
An experimental design methodology applied to the enantioseparation of a non-steroidal anti-inflammatory drug candidate 192
Cap. 21 - Antitrombotici 189
ANALYSES AND DETERMINATION OF LONIDAMINE RELEASE FROM PHARMACEUTICAL FORMULATION. 184
Combined effect of pH and polysorbates with cyclodextrins on solubilization of naringenin 182
ANALYSES AND DETERMINATION OF LONIDAMINE RELEASE FROM PHARMACEUTICAL FORMULATION. 178
A novel HPLC method for the determination of mitoxantrone in pharmaceutical formulations. 174
BETA-BLOCKERS CHARACTERIZATION BY UV-VIS ABSORPTION AND REFLECTIVITY IN DIFFERENT CHEMICAL ENVIRONMENTS 173
Study of beta-blockers/beta-cyclodextrins inclusion complex by NMR, DSC, X-ray and SEM investigation 172
ANALYSIS OF PYRROLIDONIC COMPOUNDS AS POTENTIAL ANTIOXIDANT. 172
CARATTERIZZAZIONE DI COMPLESSI D'INCLUSIONE FLAVONOIDI/CICLODESTRINE MEDIANTE:DSC,RAGGI X,DRIFT,UV-VIS 171
Comparative photodegradation studies on 3-hydroxyflavone: influence of different media, pH and light sources 171
A CHEMOMETRIC APPROACH FOR THE SEPARATION OF SOME PSYCHOTROPIC DRUGS AND THEIR METABOLITES BY LIQUID CHROMATOGRAPHY 168
COMBINED EFFECT OF pH AND CYCLODEXTRINS ON SOLUBILIZATION OF NARINGENIN 167
Analytical profile and release of lonidamine from pharmaceutical formulation 167
Characterization of limonoids in citrus essential oils by means of supercritical fluid chromatography tandem mass spectrometry (SFC-QqQ MS) 167
Rapid isolation, reliable characterization, and water solubility improvement of polymethoxyflavones from cold-pressed mandarin essential oil 167
A STUDY OF THE INCLUSION COMPLEX OF ATENOLOL WITH BETA-CYCLODEXTRIN 166
CORDIA FRANCISCI, C, MARTINICENSIS, C. MYXA, C. SERRATIFOLIA AND C. ULMIFOLIA LEAVES AS NEW SOURCES OF RUTIN: ANALGESIC AND ANTI-INFLAMMATORY ACTIVITY. 166
Characterization and isolation of limonoids in by-products of Citrus essential oils industry by means of liquid chromatography 166
Cold-pressed lemon essential oil by-products: enhancement through bioactive molecules isolation 162
AN EXPERIMENTAL DESIGN METHODOLOGY APPLIED TO THE CHIRAL SEPARATION OF A NON-STEROIDAL ANTI-INFLAMMATORY DRUG CANDIDATE 162
The rutin/beta-cyclodextrin interactions in fully aqueous solution: spectroscopic studies and biological assays 162
COMPARATIVE PHOTODEGRADATION STUDIES: INFLUENCE OF DIFFERENT MEDIA AND LIGHT SOURCES 158
ANALYSIS OF PYRROLIDONIC COMPOUNDS AS POTENTIAL ANTIOXIDANT. 155
CHROMATOGRAPHIC INVESTIGATIONS ON BROTIZOLAM 155
Cromatografia liquida ad alta efficienza nell'analisi farmaceutica: separazione e determinazione di una miscela diuretica-antipertensiva 154
ENANTIOSEPARATION AND COMPLEXATION STUDIES ON 2,3-BENZODIAZEPINES 154
Direct separation of the enantiomers of reboxetine by liquid chromatography on different cellulose- and amylose-based chiral stationary phases 152
CONFORMATIONAL SEARCH OF PHENYL SUBSTITUTED GAMMA-LACTAMIC DERIVATIVES. 152
ANALISI DI FLUNARIZINA BICLORIDRATO IN FORME FARMACEUTICHE MEDIANTE CROMATOGRAFIA LIQUIDA AD ALTA PRESSIONE 151
Optimization of a LC method for the enantio separation of a non-competitive glutamate receptor antagonist, by experimental design methodology 151
BROTIZOLAM: ANALISI E DETERMINAZIONE MEDIANTE TECNICHE CROMATOGRAFICHE. 151
SEPARAZIONE E DETERMINAZIONE MEDIANTE HPLC IN FASE INVERSA DI DERIVATI DEL 2-FENILCROMONE E DELL'ACIDO CLOROGENICO DA ESTRATTI DI CRATAEGUS OXYACANTHA L. 147
UV-vis and FTIR-ATR characterization of 9-fluorenon-2-carboxyester/(2-hydroxypropyl)-beta-cyclodextrin inclusion complex 146
Synthesis, Chiral Resolution and Pharmacological Evaluation of a 2,3-Benzodiazepine-Derived Noncompetitive AMPA Receptor Antagonist 145
REAZIONI UV-INDOTTE:FOTOCHIMICA DI COMPLESSI D'INCLUSIONE FLAVONOIDI/CICLODESTRINE. Nota II 144
RUTIN INCLUSION SYSTEMS WITH ALFA AND BETA-CYCLODEXTRINS: CIRCULAR DICHROISM, UV ABSORPTION SPECTROSCOPY AND ANTIOXIDANT ACTIVITY STUDIES 144
Drug combination studies of isoquinolinone AM12 with curcumin or quercetin: a new combination strategy to synergistically inhibit 20S proteasome 143
Development of Novel Peptidomimetics Containing a VinylSulfone Moiety as Proteasome Inhibitors 142
OPTIMIZED ENANTIOSELECTIVE HPLC METHOD FOR THE ANALYSIS OF TETRAHYDROISOQUINOLINES 141
SPECTROSCOPIC INVESTIGATION OF INCLUSION COMPLEX OF 9-FLUORENONIC DERIVATIVE WITH (2-HYDROXYPROPYL)-BETA-CYD 139
INCLUSION COMPLEXES OF SOME FLAVANONES AND THEIR GLYCOSIDES WITH MODIFIED BETA-CYLODEXTRINS 137
HPLC/PDA/MS and preparative HPLC-HPLC/PDA/MS for the characterization and isolation of limonoids in bergamot (Citrus bergamia Risso) 137
Study of the extraction procedure by experimental design and validation of a LC method for determination of flavonoids in Citrus bergamia juice 135
Determination of fludarabine in a pharmaceutical formulation by LC 134
Valorizzazione degli scarti dell'industria agroalimentare mediante l'isolamento di molecole bioattive. 133
Screening and Isolation of Citrus Bioactives by Preparative Liquid Chromatography Coupled to Photo-diode array and Mass Spectrometry Detection 133
Cap.21. Antitrombotici 131
Structural and spectroscopic features of lutein/butanoyl-beta-cyclodextrin nanoassemblies 128
BROTIZOLAM: ANALISI E DETERMINAZIONE MEDIANTE TECNICHE CROMATOGRAFICHE. 128
HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY. SEPARATION AND IDENTIFICATION OF FLAVONOIDS IN CRATAEGUS OXYACANTHA L. Note IV. Apigenin, Apigenin-7-glucoside, Luteolin, Luteolin-3',7-diglucoside 127
Effects of alpha and beta-cyclodextrin complexation on the physico-chemical properties and antioxidant activity of some 3-hydroxyflavones 127
Development of extraction method for characterization of free and bonded polyphenols in barley (Hordeum vulgare L.) grown in Czech Republic using liquid chromatography-tande, mass spectrometry 125
Improvement in solubility and dissolution rate of flavonoids by complexation with beta-cyclodextrin 124
MISURE DI LIPOFILICITA' DI FLAVONI MEDIANTE CROMATOGRAFIA LIQUIDA IN FASE INVERSA 122
Study of the inclusion complex of atenolol with beta- cyclodextrins 121
Validation of a LC method for the analysis of oxaliplatin in a pharmaceutical formulation using an experimental design 120
Selective reversed-phase liquid chromatography method for the kinetic investigation of 3-hydroxyflavone photostability 120
MOLECULAR MODELING OF ENANTIOSELECTIVE RECOGNITION BETWEEN GAMMA-LACTAMIC DERIVATIVES AND CHIRALCEL OD CHIRAL STATIONARY PHASE. 119
Determinazione del trans-1-bis(4-fluorofenil)metil-4-(3-fenil-2-propenil)piperazina dicloridrato mediante HPLC 119
Cromatografia liquida nell'analisi farmaceutica: determinazione nelle compresse della famotidina, nuovo H2-antagonista 118
ISOFLAVONES AND CYCLODEXTRINS: EVIDENCES OF COMPLEXATION BY COMPLEMENTARY SPECTROSCOPIC TECHNIQUES 118
UV-INDUCED REACTIONS:EFFECTS OF MICROENVIROMENT ON FLAVONOIDS PHOTOCHEMISTRY 117
The inclusion complexes of hesperetin and its 7-rhamnoglucoside with (2-hydroxypropyl)-beta-cyclodextrin 116
HPLC DIASTEREO ED ENANTIOSELETTIVA DI 2-ARIL-4-TIAZOLIDINONI SOSTITUITI. 116
TECNICHE CHEMOMETRICHE PER L'OTTIMIZZAZIONE DI METODOLOGIE STRUMENTALI IN ANALISI FARMACEUTICA 115
STUDI COMPUTAZIONALI NELLA RICOGNIZIONE CHIRALE DI DERIVATI GAMMA-LATTAMICI AD AZIONE ANTIOSSIDANTE 113
Dosaggio mediante HPLC di atenololo e clortalidone associati in forme farmaceutiche 113
FORCE FIELD COMPARISONS AND CONFORMATIONAL ANALYSIS OF STRUCTURES INTERESTING IN PHARMACEUTICAL RESEARCH. 112
CORDIA FRANCISCI, C. MARTINICENSIS, C. MYXA, C. SERRATIFOLIA AND C. ULMIFOLIA LEAVES: A NEW SOURCES OF RUTIN. ANALGESIC AND ANTIINFLAMMATORY ACTIVITY 111
CROMATOGRAFIA LIQUIDA NELL'ANALISI FARMACEUTICA: SEPARAZIONE E DETERMINAZIONE DI FAMOTIDINA, NUOVO H2-ANTAGONISTA 110
Synthesis and biological evaluation of new 2-amino-6-(trifluoromethoxy)benzoxazole derivatives, analogues of riluzole. 110
Study of flavonoids/beta-cyclodextrins inclusion complexes by NMR, FT-IR, DSC, X-ray investigation 108
DIRECT ENANTIOMERIC SEPARATION OF REBOXETINE BY LIQUID CHROMATOGRAPHY USING DIFFERENT CELLULOSE AND AMYLOSE BASED CHIRAL STATIONARY PHASES 108
Diastereo-enantioseparation of N-Acetyl-1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives on cellulose chiral stationary phases 107
RISOLUZIONE ENANTIOMERICA DI GAMMA-LATTAMI MEDIANTE HPLC. 106
STRUCTURAL AND CONFORMATIONAL STUDY OF BETA-BLOCKERS/BETA-CYCLODEXTRIN COMPLEXES 105
HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND DIFFUSE REFLECTANCE SPECTROSCOPY OF FLAVONOIDS IN CRATEGUS-OXYACANTHA L .3. ANALYSIS OF 2-PHENYL-CHROMAN DERIVATIVES AND CAFFEIC ACID 105
CROMATOGRAFIA LIQUIDA AD ALTA RISOLUZIONE NELL'ANALISI DI PREPARAZIONI ESTRATTIVE DI FOGLIE E GERMOGLI DI OLEA EUROPAEA L. 104
PHOTODEGRADATION STUDY ON 3-HYDROXYFLAVONE BY HPLC. 104
Synthesis of benzothiazole derivatives and their biological evaluation as anticancer agents 104
HPLC-DAD AND TLC OF FLAVONOIDS FROM LEAF EXTRACTIVES OF GENUS CORDIA. 103
Sensitive and specific determination of epirubicin and epirubicinol by HPLC. 103
PHARMACEUTICAL APPLICATION OF BETA-CYCLODEXTRIN: INCLUSION COMPLEXES WITH BETA-BLOCKERS 103
FORCE FIELD COMPARISONS AND CONFORMATIONAL ANALYSIS OF STRUCTURES INTERESTING IN PHARMACEUTICAL RESEARCH. 100
Diastereo-enantioseparation of novel gamma-lactamic derivatives on cellulose chiral stationary phases 99
STRUCTURAL AND THERMODYNAMIC STUDY OF BETA-BLOCKERS/BETA-CYCLODEXTRIN INCLUSION COMPLEXES 99
ENANTIOMERIC SEPARATION BY HPLC OF FLAVANONES AND FLAVANS WITH ANTIOXYDANT ACTIVITY. 98
Dosaggio HPLC della roxatidina, prove di stabilità e rilascio da formulazioni farmaceutiche. 98
ENANTIOMERIC SEPARATION BY HPLC OF FLAVANONES AND FLAVANS WITH ANTIOXYDANT ACTIVITY. 98
HYDRATATION EFFECT ON THE MICELLAR STRUCTURE OF TRI-BLOCK COPOLYMER IN WATER (VISCOELASTIC RESULTS). 98
MODIFIED CYCLODEXTRINS IN THE SOLUBILIZATION OF SOME PHYTOESTROGENS 97
HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY OF FLAVONOIDS IN CRATAEGUS-OXYACANTHA L .4. REVERSED-PHASE HIGH-PRESSURE LIQUID- CHROMATOGRAPHY IN FLOWER, LEAF AND BUD EXTRACTIVES OF CRATAEGUS-OXYACANTHA L 97
VALIDATION OF A LIQUID CROMATOGRAPHIC METHOD FOR THE ANALYSIS OF ZAFIRLUKAST IN A PHARMACEUTICAL FORMULATION 96
VALIDATION OF A LC METHOD FOR THE ANALYSIS OF OXALIPLATIN IN A PHARMACEUTICAL FORMULATION USING EXPERIMENTAL DESIGN 96
SIMULTANEOUS DETERMINATION OF METAPROLOL AND HYDROCLOROTHIAZIDE IN TWO COMPONENT TABLET FORMULATIONS BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY 95
Totale 13.720
Categoria #
all - tutte 61.104
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.104


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.088 0 233 13 28 20 2 80 44 6 126 202 334
2022/20232.743 198 197 137 191 259 263 52 170 1.128 12 110 26
2023/2024488 62 93 39 59 54 103 7 18 0 22 2 29
2024/20252.707 35 32 54 180 122 30 48 611 704 159 237 495
2025/20267.826 374 445 515 522 643 1.865 1.109 915 924 293 100 121
2026/2027137 118 19 0 0 0 0 0 0 0 0 0 0
Totale 18.490